InVivo Therapeutics announced the FDA has given the company conditional approval to convert an ongoing study into the pivotal probable benefit study called, “ The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurological